Expression of CD44 and its isoforms in the fetal neuroblasts

Applied Immunohistochemistry and Molecular Morphology

Volumn 9, Issue 2, 2001, Pages 180-184

  Kaya, Gürkan ^a,b   Laurini, Ricardo ^a   Chaubert, Pascal ^a   Gross, Nicole ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Adrenal gland cells; CD44 standard and isoforms; Fetal neuroblasts; Human neuroblastoma

Indexed keywords

CD44V ANTIGEN; CD44V6 ANTIGEN; CD44V7 ANTIGEN; HERMES ANTIGEN; ISOPROTEIN; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENICITY; CELL MIGRATION; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; NEUROBLAST; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN PROCESSING;

ADRENAL GLANDS; ADRENERGIC FIBERS; ANTIGENS, CD44; FETUS; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; NEURONS; PROTEIN ISOFORMS;

EID: 0035009785     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200106000-00012     Document Type: Article

References (30)

1. Stamenkovic I, Aruffo A, Amiot M, et al. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991; 10:343-8.
2. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD-44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89:12160-4.
3. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993;54:271-335.
4. Bartolazzi, A, Peach R, Aruffo A, et al. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994;180:53-66.
5. Kaya G, Rodriguez I, Jorcano JL, et al. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 1997;11:996-1007.
6. Kaya G, Rodriguez I, Jorcano JL, et al. Cutaneous delayed-type hypersensitivity response is inhibited in transgenic mice with keratinocyte-specific CD44 expression defect J Invest Dermatol 1999;113:137-8.
7. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function and association with the malignant process. Adv Cancer Res 1997;71: 241-319.
8. Salmi M, Grön-Virta K, Sointu P, et al. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993;122:431-42.
9. Fujita N, Yaegashi N, Ide Y, et al. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res 1994;54:3922-8.
10. Brodeur GM. Molecular basis for heterogeneity in human neuroblastoma. EurJ Cancer 1995;31A:505-10.
11. Cooper MJ, Steinberg SM, Chatten J, et al. Plasticity of neuroblastoma tumor cells to differentiate along fetal adrenal ganglionic lineage predicts for improved patient survival. J Clin Invest 1992; 90:2402-8.
12. Gross N, Beretta C, Peruisseau G, et al. CD44H expression by human neuroblastoma cells relation to MYCN amplification and lineage differentiation. Cancer Res 1994;54:4238-42.
13. Jakobovits A, Schwab M, Bishop JM, et al. Expression of N-myc in teratocarcinoma stem cells and mouse embryos. Nature 1985; 318:188-91.
14. Su BS, Strand D, MacDonough PG, et al. Temporal and constitutive expression of homeobox gene (hu-2), human heat shock gene (hsp-70), and oncogenes Cis and N-myc in early human trophoblasts. Am J Obstet Gynecol 1988;159:1195-9.
15. Dalchau R, Kirkley R, Fabre JW. Monoclonal antibody to a human brain-granulocyte T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat. Eur J Immunol 1980;10:745-9.
16. Sternberger LA, Hardy PH Jr, Cuculis J, et al. The unlabeled antibody enzyme method of immunochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 1970;18:315-33.
17. Shi SR, Key ME, Karla KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating on tissue sections. J Histochem Cytochem 1991;39:741-8.
18. Terpe HJ, Stark H, Prehm P, et al. CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues. Histochemistry 1994;101:79-89.
19. Oksala O, Salo T, Tammi R, et al. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem 1995; 43:125-35.
20. Thomas L, Etoh T, Stamenkovic I, et al. Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol 1993;100:115-20.
21. Seiter S, Tilgen W, Herrmann K, et al. Expression of CD44 splice variants in human skin and epidermal tumors. Virchows Arch 1996;428(3):141-9.
22. Dall P, Hekele A, Ikenberg H, et al. Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis. Int J Cancer 1996;69(2):79-85.
23. Combaret V, Gross N, Lasset C, et al. Clinical relevance of CD44 cell surface expression and MYCN gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J Clin Oncol 1996;14:25-34.
24. Barshack I, Goldberg I, Nass D, et al. CD44 expression in normal adrenal tissue and adrenal tumors. J Clin Pathol 1998;51(1):52-4.
25. Seiter S, Schadendorf D, Herrmann K, et al. Expression of CD44 variant isoforms in malignant melanoma. Clin Cancer Res 1996; 2(3):447-56.
26. Moretto G, Xu RY, Kim SU. CD44 expression in human astrocytes and oligodendrocytes in culture. J Neuropathol Exp Neurol 1993; 52(4):419-23.
27. Kondo K, Miyoshi T, Hino N, et al. High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers. J Surg Oncol 1998;69(3): 128-36.
28. Gross N, Miescher G, Beck D, et al. Altered growth and phenotype in clonal MYCN transfectants of the SK-N-SH neuroblastoma cell line. Int J Cancer 1994;59:141-8.
29. Gross N, Balmas K, Beretta Brognara C. Absence of functional CD44 hyaluronan receptor on human MYCN amplified neuroblastoma cells. Cancer Res 1997;57:1387-93.
30. Stanton BR, Perkins AS, Tessarollo L, et al. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 1992;6(12A): 2235-47.